Type 1 Diabetes Mellitus and Premature Coronary Artery Disease
DOI:
https://doi.org/10.21776/ub.hsj.2022.003.03.2Keywords:
Type 1 Diabetes Mellitus, Premature Coronary Artery Disease, Risk FactorAbstract
Cardiovascular disease, which affects more than half of all diabetics, is the leading cause of morbidity and mortality in patients with type 1 and type 2 Diabetes Mellitus (DM). Around 55% of diabetes patients are thought to have it, in comparison to 2-4% of the general population. A significant risk factor for the development of Coronary Artery Disease (CAD) exists in people with Type 1 Diabetes Mellitus (T1DM). However, it is worth noting that the present Models of risk prediction for T1DM have a variety of flaws. CAD risk is expected to double or quadruple over the next two to four decades, and diabetes mellitus is the third most significant risk factor for the etiology of illness. As a result, diabetes increases the chance of developing Acute Coronary Syndromes (ACS), whose incidence surpasses 20% after seven years, compared to a rate of 3.5 percent in non-diabetics – a rate comparable to individuals who have already experienced an Acute Myocardial Infarction (AMI). Additionally, it is crucial to identify any well-defined specific risk factors for T1DM as well as any extra subclinical atherosclerosis that may influence these patients at an advanced stage of disease progression. T1DM patients have more severe lesions, a lower left ventricle (LV) ejection fraction, a higher risk of cardiac events, and a higher rate of silent ischemia when compared to non-diabetics. They continue to have impaired microcirculation and endothelial function, both of which contribute to tissue perfusion problems.
References
Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Poor Glycemic Control Predicts Coronary Heart Disease Events in Patients With Type 1 Diabetes Without Nephropathy. Vol 19.; 1999. http://www.atvbaha.org
Zgibor JC, Piatt GA, Ruppert K, Orchard TJ, Roberts MS. Deficiencies of cardiovascular risk prediction models for type 1 diabetes. Diabetes Care. 2006;29(8):1860-1865. doi:10.2337/dc06-0290
Yusuf S, Hawken S, Ôunpuu S, Dans T. yusuf2004, effect modified risk factor in ACS.
Zgibor JC, Piatt GA, Ruppert K, Orchard TJ, Roberts MS. Deficiencies of cardiovascular risk prediction models for type 1 diabetes. Diabetes Care. 2006;29(8):1860-1865. doi:10.2337/dc06-0290
Saldanha De Mattos Matheus A, Brito Gomes M. Early aggressive macrovascular disease and type 1 diabetes mellitus without chronic complications: A case report. BMC Research Notes. 2013;6(1). doi:10.1186/1756-0500-6-222
Orchard TJ, Costacou T, Kretowski A, Nesto RW. Type 1 diabetes and coronary artery disease. Diabetes Care. 2006;29(11):2528-2538. doi:10.2337/dc06-1161
Saberzadeh-Ardestani B, Karamzadeh R, Basiri M, et al. Type 1 diabetes mellitus: Cellular and molecular pathophysiology at a glance. Cell Journal. 2018;20(3):294-301. doi:10.22074/cellj.2018.5513
Walsh MG, Zgibor J, Borch-Johnsen K, Orchard TJ. A Multinational Comparison of Complications Assessment in Type 1 Diabetes The DiaMond Substudy of Complications (DiaComp) Level 2 ON BEHALF OF THE DIACOMP INVESTIGATORS*.; 2004.
Snell-Bergeon JK, Roman R, Rodbard D, et al. Glycaemic variability is associated with coronary artery calcium in men with Type 1 diabetes: The coronary artery calcification in Type 1 diabetes study. Diabetic Medicine. 2010;27(12):1436-1442. doi:10.1111/j.1464-5491.2010.03127.x
Sousa GR, Pober D, Galderisi A, et al. Glycemic control, cardiac autoimmunity, and long-term risk of cardiovascular disease in type 1 diabetes mellitus A DCCT/EDIC cohort–based study. Circulation. 2019;139(6):730-743. doi:10.1161/CIRCULATIONAHA.118.036068
Sharma H, Lencioni M, Narendran P. Cardiovascular disease in type 1 diabetes. Cardiovascular Endocrinology and Metabolism. 2019;8(1):28-34. doi:10.1097/XCE.0000000000000167
Orchard TJ, Costacou T, Kretowski A, Nesto RW. Type 1 diabetes and coronary artery disease. Diabetes Care. 2006;29(11):2528-2538. doi:10.2337/dc06-1161
Miettinen H, Lehto S, Salomaa V, et al. Impact of diabetes on mortality after the first myocardial infarction. Diabetes Care. 1998;21(1):69-75. doi:10.2337/diacare.21.1.69
Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115(3):387-397. doi:10.1161/CIRCULATIONAHA.106.634949
Bissinger A. Cardiac Autonomic Neuropathy: Why Should Cardiologists Care about That? Journal of Diabetes Research. 2017;2017. doi:10.1155/2017/5374176
Colhoun HM, Francis DP, Rubens MB, Underwood SR, Fuller JH. The Association of Heart-Rate Variability With Cardiovascular Risk Factors and Coronary Artery Calcification A Study in Type 1 Diabetic Patients and the General Population.
Pop-Busui R, Braffett BH, Zinman B, et al. Cardiovascular autonomic neuropathy and cardiovascular outcomes in the diabetes control and complications trial/ epidemiology of diabetes interventions and complications (DCCT/EDIC) Study. Diabetes Care. 2017;40(1):94-100. doi:10.2337/dc16-1397
Gomes MB, Cobas RA, Nunes E, et al. Plasma PAF-acetylhydrolase activity, inflammatory markers and susceptibility of LDL to in vitro oxidation in patients with type 1 diabetes mellitus. Diabetes Research and Clinical Practice. 2009;85(1):61-68. doi:10.1016/j.diabres.2009.04.016
Beckman JA, Creager MA, Libby P. Diabetes and Atherosclerosis Epidemiology, Pathophysiology, and Management. http://jama.jamanetwork.com/
Rodrigues TC, Snell-Bergeon JK, Maahs DM, Kinney GL, Rewers M. Higher Fibrinogen Levels Predict Progression of Coronary Artery Calcification in Adults with Type 1 Diabetes. Atherosclerosis. 2010;210(2):671-673. doi:10.1016/j.atherosclerosis.2009.12.034
Lopes-Virella MF, Bebu I, Hunt KJ, et al. Immune complexes and the risk of CVD in type 1 diabetes. Diabetes. 2019;68(9):1853-1860. doi:10.2337/db19-0358
Basu A, Jenkins AJ, Zhang Y, et al. Data on carotid intima-media thickness and lipoprotein subclasses in type 1 diabetes from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC). Data in Brief. 2016;6:33-38. doi:10.1016/j.dib.2015.11.036
Hunt KJ, Baker N, Cleary P, et al. Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes. Atherosclerosis. 2013;231(2):315-322. doi:10.1016/j.atherosclerosis.2013.09.027
Devaraj S, Cheung AT, Jialal I, et al. Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Diabetes. 2007;56(11):2790-2796. doi:10.2337/db07-0784
Harding SA, Sommerfield AJ, Sarma J, et al. Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus. Atherosclerosis. 2004;176(2):321-325. doi:10.1016/j.atherosclerosis.2004.05.008
Hokanson JE, Cheng S, Snell-Bergeon JK, et al. A Common Promoter Polymorphism in the Hepatic Lipase Gene (LIPC-480C>T) Is Associated With an Increase in Coronary Calcification in Type 1 Diabetes. Vol 51.; 2002.
Simpson M, Snell-Bergeon JK, Kinney GL, et al. Haptoglobin Genotype Predicts Development of Coronary Artery Calcification in a Prospective Cohort of Patients with Type 1 Diabetes.; 2011. http://www.cardiab.com/content/10/1/99
Söderlund J, Forsblom C, Ilonen J, et al. HLA class II is a factor in cardiovascular morbidity and mortality rates in patients with type 1 diabetes. Diabetologia. 2012;55(11):2963-2969. doi:10.1007/s00125-012-2670-6
Dabelea D, Kinney G, Snell-Bergeon JK, et al. Effect of Type 1 Diabetes on the Gender Difference in Coronary Artery Calcification: A Role for Insulin Resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study.; 2003.
Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021;64(12):2609-2652. doi:10.1007/s00125-021-05568-3
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).